Panel Discussion
Panelists:
Moderator: Trond Undheim, Ph.D., Lead, MIT Startup Exchange, MIT ILP
David Shrier, CEO & founder, Distilled Identity
Erik Vogan, PhD, MBA, Program Director, MIT Corporate Relations Industrial Liaison Program
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
Interpretable AI co-founders, Jack Dunn and Daisy Zhuo
Alan Ringvald, CEO & Cofounder, Relativity6
Emilio Frazzoli, MIT Professor of Aeronautics & Astronautics, nuTonomy CTO
Ben Vigoda, CEO
Sertac Karaman, Cofounder, Optimus Ride
Vincent Ling, Senior Director, Materials and Innovation, Takeda